About
Technology
Issues
FAQ
Links
Official Page
A randomized, double‐blind, placebo‐controlled phase II study of eculizumab in patients with refractory generalized myasthenia gravis
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.